Adagio Medical (ADGM) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trinity Biotech is the larger company by market cap ($5.5 million vs $3.4 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADGM | TRIB |
|---|---|---|
| Share price | $0.1262 | $6.82 |
| Market cap | $3.43M | $5.55M |
| 1-day change | -2.92% | +12.91% |
| EPS (TTM) | $-1.37 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.58 | $52.50 |
| 52-week low | $0.12 | $5.01 |
| Distance from 52-week high | -95.11% | -87.01% |
| Analyst consensus | none | — |
| Avg. price target upside | +2538.67% | — |
| Average volume | 9.07M | 21.66K |
| Shares outstanding | 27.19M | 813.13K |
| Employees | 41 | 287 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Adagio Medical
ADGM stock →Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia.
Health Care · Medical/Dental Instruments · 41 employees
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 287 employees
ADGM vs TRIB FAQ
Which is bigger, Adagio Medical or Trinity Biotech?
Trinity Biotech (TRIB) is larger, with a market capitalization of $5.55M compared with $3.43M for Adagio Medical (ADGM).
Are Adagio Medical and Trinity Biotech in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Adagio Medical and Biotechnology: In Vitro & In Vivo Diagnostic Substances for Trinity Biotech.